Seattle Genetics says cancer drug met study goal
Oct 11, 2010 12:02:17 PM - komonews.com
The company said 50 of the 58 patients in the study responded to treatment with brentuximab. All the patients had anaplastic large cell lymphoma that had recurred or not responded to previous treatment.
USA, Washington: (Latest Stories)